Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT00135720
Eligibility Criteria:
Summary Inclusion Criteria:
* Understand and sign the written informed consent form and be willing and able to comply with the procedures of the study
* Have a clinical diagnosis of pemphigus vulgaris
* Have at least 6 active pemphigus lesions (blisters or erosions)
* Have no adverse effects due to combining etanercept with concurrent pemphigus medications
* Be on stable dose of current pemphigus medications for at least one month
* Females of child-bearing potential must have a negative urine pregnancy test prior to treatment and agree to practice an acceptable method of birth control (oral contraceptives, hormonal implant devices, Depo-Provera, condom with spermicide, diaphragm with contraceptive cream or foam, or intrauterine device) during the course of the study
* Be at least 18 years old at time of enrollment
* Be able to adhere to the study visit schedule and other protocol requirements
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00135720
Study Brief:
Protocol Section:
NCT00135720